Keyphrases
Familial Mediterranean Fever
100%
Familial Mediterranean Fever Patient
38%
Amyloidosis
22%
Colchicine
22%
Giant Cell Arteritis
16%
Temporal Artery Biopsy
12%
Clinical Features
11%
Free Light Chains
11%
Systemic Lupus Erythematosus
10%
Risk Factors
10%
Anakinra
9%
MEFV Gene
9%
Immunoglobulin Free Light Chains
8%
Mediterranean Fever Gene
8%
Saliva
8%
Exercise-induced Leg Pain
7%
Disease Activity
7%
Colchicine-resistant Familial Mediterranean Fever
7%
Pharmacovigilance
6%
Colchicine Treatment
6%
Inflammation
6%
Magnetic Resonance Imaging
6%
Clinical Significance
6%
M694V
6%
AL Amyloidosis
6%
Adverse Events
6%
Cardiovascular Risk
6%
Multiple Sclerosis
6%
Arteritis
5%
QT Dispersion
5%
Clinical Prognosis
5%
Coronary Artery Calcification
5%
Clinical Predictors
5%
COVID-19
5%
Janus Kinase Inhibitors
5%
Confidence Interval
5%
Israel
5%
Remission
5%
Pharmacology, Toxicology and Pharmaceutical Science
Familial Mediterranean Fever
59%
Colchicine
21%
Diseases
19%
Systemic Lupus Erythematosus
11%
Amyloidosis
10%
Anakinra
9%
Inflammation
8%
Adverse Event
8%
Rheumatic Disease
8%
Infection
7%
Prevalence
7%
Pharmacovigilance
6%
Rheumatoid Arthritis
6%
Inflammatory Arthritis
6%
Leg Pain
6%
Tumor Necrosis Factor
5%
AA Amyloidosis
5%
Janus Kinase Inhibitor
5%
Interleukin 1
5%
Placebo
5%
Cardiovascular Disease
5%
Medicine and Dentistry
Familial Mediterranean Fever
39%
Giant-Cell Arteritis
16%
Temporal Artery
14%
Amyloidosis
13%
Blood Vessel Biopsy
12%
Diseases
11%
Light Chain
8%
Rheumatic Disease
8%
AA Amyloidosis
7%
Clinical Feature
7%
Cardiovascular System
6%
Arteritis
5%
Leg Pain
5%
Immunoglobulin
5%
Proteinuria
5%
Nephropathy
5%
Amyloid Protein
5%
Biopsy Technique
5%
